NOL12

gene
On this page

Also known as MGC3731Nop25RRP17

Summary

NOL12 (nucleolar protein 12, HGNC:28585) is a protein-coding gene on chromosome 22q13.1, encoding Nucleolar protein 12 (Q9UGY1). Multifunctional RNA binding protein that plays a role in RNA metabolism and DNA maintenance. It is a selective cancer dependency (DepMap: 79.6% of cell lines).

Enables identical protein binding activity. Predicted to be located in cytoplasm and nucleus. Predicted to be active in nucleolus.

Source: NCBI Gene 79159 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 55 total
  • Cancer dependency (DepMap): dependent in 79.6% of screened cell lines
  • MANE Select transcript: NM_024313

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28585
Approved symbolNOL12
Namenucleolar protein 12
Location22q13.1
Locus typegene with protein product
StatusApproved
AliasesMGC3731, Nop25, RRP17
Ensembl geneENSG00000273899
Ensembl biotypeprotein_coding
Entrez79159

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 3 protein_coding, 3 retained_intron, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined

ENST00000359114, ENST00000438329, ENST00000468597, ENST00000474032, ENST00000484650, ENST00000493862, ENST00000611699, ENST00000902787

RefSeq mRNA: 1 — MANE Select: NM_024313 NM_024313

CCDS: CCDS13955

Canonical transcript exons

ENST00000359114 — 6 exons

ExonStartEnd
ENSE000014105713769117437693474
ENSE000037214693769069737690794
ENSE000037314003768885037688992
ENSE000037370603768791037688015
ENSE000037522713768831237688360
ENSE000038503063768634337686475

Expression profiles

Bgee: expression breadth ubiquitous, 197 present calls, max score 92.21.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 21.2167 / max 163.6229, expressed in 1810 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
19218316.91411810
1921844.26611625
1921820.02353
1921800.00823
1921810.00473

Top tissues by expression

266 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
sural nerveUBERON:001548892.21gold quality
right testisUBERON:000453492.07gold quality
left testisUBERON:000453391.91gold quality
monocyteCL:000057691.79gold quality
mononuclear cellCL:000084291.41gold quality
mucosa of transverse colonUBERON:000499191.34gold quality
leukocyteCL:000073891.02gold quality
lower esophagus mucosaUBERON:003583490.52gold quality
right hemisphere of cerebellumUBERON:001489089.62gold quality
right adrenal glandUBERON:000123389.56gold quality
esophagus mucosaUBERON:000246989.32gold quality
granulocyteCL:000009489.19gold quality
cerebellar hemisphereUBERON:000224589.18gold quality
left adrenal gland cortexUBERON:003582589.15gold quality
left adrenal glandUBERON:000123489.12gold quality
right adrenal gland cortexUBERON:003582789.09gold quality
cerebellar cortexUBERON:000212989.07gold quality
C1 segment of cervical spinal cordUBERON:000646988.83gold quality
right lobe of thyroid glandUBERON:000111988.11gold quality
transverse colonUBERON:000115787.67gold quality
testisUBERON:000047387.43gold quality
left lobe of thyroid glandUBERON:000112087.39gold quality
adrenal cortexUBERON:000123587.05gold quality
anterior cingulate cortexUBERON:000983587.00gold quality
cingulate cortexUBERON:000302786.84gold quality
right frontal lobeUBERON:000281086.66gold quality
cerebellumUBERON:000203786.65gold quality
ectocervixUBERON:001224986.55gold quality
skin of abdomenUBERON:000141686.53gold quality
minor salivary glandUBERON:000183086.47gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes6.36

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

33 targeting NOL12, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-200B-3P100.0073.312693
HSA-MIR-200C-3P100.0073.352685
HSA-MIR-429100.0073.442698
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-3680-3P99.7572.513095
HSA-MIR-430699.7270.503630
HSA-MIR-320299.6667.702737
HSA-MIR-6715B-5P99.6469.631420
HSA-MIR-466399.6265.33957
HSA-MIR-426999.5569.891373
HSA-MIR-6733-3P99.5467.801281
HSA-MIR-1207-5P99.4969.112983
HSA-MIR-444199.4966.563216
HSA-MIR-185-5P99.3568.602497
HSA-MIR-504-3P99.3067.181745
HSA-MIR-5589-3P99.2968.301443
HSA-MIR-3692-5P99.2967.041421
HSA-MIR-5582-5P99.2771.421879
HSA-MIR-6852-5P99.1766.692073
HSA-MIR-4763-3P99.1067.832649
HSA-MIR-1909-5P98.9464.01484
HSA-MIR-6760-5P98.8766.731515
HSA-MIR-6715B-3P98.8068.071204
HSA-MIR-3135B98.6165.331470
HSA-MIR-4726-3P98.4963.891385
HSA-MIR-7156-3P98.2567.66859
HSA-MIR-4664-5P98.1765.071020
HSA-MIR-6765-3P97.8364.591165
HSA-MIR-194-3P97.3665.961027
HSA-MIR-342-5P97.2564.10817

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 79.6% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 3)

  • Nol12 is an RNA binding protein required for both ribosome maturation and genome integrity (PMID:29069457)
  • Results show that NOL12 is important for nucleolar homeostasis, regulating its structure and the nucleolar levels of the multifunctional fibrillarin and nucleolin proteins. Moreover, NOL12 depletion to induce strong p53 activation leading to cell senescence suggesting an important role for NOL12 in replicative and chronological aging and its potential as aging biomarker. (PMID:30988155)
  • The human cellular protein NoL12 is a specific partner of the HIV-1 nucleocapsid protein NCp7. (PMID:37695057)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_rerionol12ENSDARG00000038027
mus_musculusNol12ENSMUSG00000033099
rattus_norvegicusNol12ENSRNOG00000010209

Protein

Protein identifiers

Nucleolar protein 12Q9UGY1 (reviewed: Q9UGY1)

All UniProt accessions (1): Q9UGY1

UniProt curated annotations — full annotation on UniProt →

Function. Multifunctional RNA binding protein that plays a role in RNA metabolism and DNA maintenance. Participates in the resolution of DNA stress and the maintenance of genome integrity by localizing to sites of DNA insults. Also plays a role in proper nucleolar organization by limiting nucleolar size and regulating nucleolar number. Mechanistically, regulates the nucleolar levels of fibrillarin and nucleolin, two key players in pre-rRNA processing and ribosome assembly.

Subunit / interactions. Interacts with KIAA1191.

Subcellular location. Nucleus. Nucleolus. Cytoplasm.

Similarity. Belongs to the RRP17 family.

RefSeq proteins (1): NP_077289* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR019186Nucleolar_protein_12Family

Pfam: PF09805

UniProt features (7 total): compositionally biased region 2, mutagenesis site 2, chain 1, region of interest 1, coiled-coil region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9UGY1-F174.940.31

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Mutagenesis-validated functional residues (2):

PositionPhenotype
21loss of dna damage response pathway activation.
23loss of dna damage response pathway activation.

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-6791226Major pathway of rRNA processing in the nucleolus and cytosol

MSigDB gene sets: 108 (showing top): SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2, TATA_C, DOUGLAS_BMI1_TARGETS_UP, MODULE_397, GOMF_SINGLE_STRANDED_DNA_BINDING, REACTOME_METABOLISM_OF_RNA, chr22q13, GOCC_NUCLEOLUS, SCGGAAGY_ELK1_02, MGGAAGTG_GABP_B, GEORGES_TARGETS_OF_MIR192_AND_MIR215, MANALO_HYPOXIA_DN, GOMF_RRNA_BINDING, AKT_UP_MTOR_DN.V1_UP, SRC_UP.V1_DN

GO Biological Process (0):

GO Molecular Function (5): single-stranded DNA binding (GO:0003697), RNA binding (GO:0003723), rRNA binding (GO:0019843), identical protein binding (GO:0042802), protein binding (GO:0005515)

GO Cellular Component (3): nucleolus (GO:0005730), cytoplasm (GO:0005737), nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
rRNA processing in the nucleus and cytosol1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
DNA binding1
nucleic acid binding1
RNA binding1
protein binding1
binding1
nuclear lumen1
intracellular membraneless organelle1
intracellular anatomical structure1
cellular anatomical structure1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

1326 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
NOL12BOP1Q14137615
NOL12RRP1P56182531
NOL12EBNA1BP2Q99848528
NOL12RRP7AQ9Y3A4493
NOL12RBM28Q9NW13478
NOL12NOL6Q9H6R4474
NOL12XRN2Q9H0D6473
NOL12WDR12Q9GZL7460
NOL12RBMXP38159433
NOL12UTP18Q9Y5J1431
NOL12A0A0A6YYI9A0A0A6YYI9425
NOL12KIAA1191Q96A73422
NOL12RPF2Q9H7B2421
NOL12NOP56O00567411
NOL12RBM14Q96PK6410

IntAct

126 interactions, top by confidence:

ABTypeScore
CEP70NOL12psi-mi:“MI:0915”(physical association)0.670
NOL12CEP70psi-mi:“MI:0915”(physical association)0.670
H1-1RRP8psi-mi:“MI:0914”(association)0.640
NOL12RRP8psi-mi:“MI:0914”(association)0.640
RPL7ANOP56psi-mi:“MI:0914”(association)0.640
NPM1MPHOSPH10psi-mi:“MI:0914”(association)0.610
KRTAP10-7NOL12psi-mi:“MI:0915”(physical association)0.560
DVL3NOL12psi-mi:“MI:0915”(physical association)0.560
SSX2IPNOL12psi-mi:“MI:0915”(physical association)0.560
NOL12KRTAP10-7psi-mi:“MI:0915”(physical association)0.560
NOL12DVL3psi-mi:“MI:0915”(physical association)0.560
NOL12SSX2IPpsi-mi:“MI:0915”(physical association)0.560
CDCA7LNOL12psi-mi:“MI:0915”(physical association)0.560
MCCNOL12psi-mi:“MI:0915”(physical association)0.560
KRTAP10-6NOL12psi-mi:“MI:0915”(physical association)0.560
TSPYL2NOL12psi-mi:“MI:0915”(physical association)0.560
BEND7NOL12psi-mi:“MI:0915”(physical association)0.560
SPANXN2NOL12psi-mi:“MI:0915”(physical association)0.560
NOL12NOL12psi-mi:“MI:0915”(physical association)0.560
H1-6ZNF724psi-mi:“MI:0914”(association)0.530
MAK16NVLpsi-mi:“MI:0914”(association)0.530
ZCRB1DKC1psi-mi:“MI:0914”(association)0.530
BHLHA15RPLP0psi-mi:“MI:0914”(association)0.530

BioGRID (248): NOL12 (Two-hybrid), CEP70 (Two-hybrid), SSX2IP (Two-hybrid), KRTAP10-7 (Two-hybrid), NOL12 (Affinity Capture-MS), LARP7 (Affinity Capture-MS), CCDC137 (Affinity Capture-MS), KNOP1 (Affinity Capture-MS), RBM28 (Affinity Capture-MS), SF3B1 (Affinity Capture-MS), MRPS9 (Affinity Capture-MS), FTSJ3 (Affinity Capture-MS), MRPS26 (Affinity Capture-MS), SF3B2 (Affinity Capture-MS), DDX50 (Affinity Capture-MS)

ESM2 similar proteins: A1A5P2, A6QNR1, A8WY26, D3ZND0, O15213, O59678, P27672, P78316, Q0V8M0, Q15050, Q24K12, Q28IV8, Q2KIH4, Q2KII6, Q3T0Q8, Q3T0Z5, Q3UFY0, Q4KLC4, Q5M985, Q5RAS1, Q5RJT2, Q5TAP6, Q5TJE7, Q5ZKM1, Q640M1, Q6EJB6, Q6P0I6, Q6PFJ1, Q8BK35, Q8IY81, Q8N9T8, Q8NEJ9, Q8R3N1, Q8VDQ9, Q96BZ8, Q96EU6, Q9BRP8, Q9BRR8, Q9BVJ6, Q9C086

Diamond homologs: O14012, Q04031, Q0IH29, Q2KIV0, Q5D1Z3, Q5RD68, Q640V3, Q8BG17, Q9UGY1, Q7ZWE7

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 108 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Eukaryotic Translation Initiation835.8×7e-10
Cap-dependent Translation Initiation835.8×7e-10
SARS-CoV-1 modulates host translation machinery835.8×7e-10
Peptide chain elongation1934.9×6e-23
Viral mRNA Translation1934.9×6e-23
PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA1934.6×6e-23
Selenocysteine synthesis1933.1×9e-23
Eukaryotic Translation Termination1933.1×9e-23

GO biological processes:

GO termPartnersFoldFDR
cytoplasmic translation2038.2×4e-24
ribosomal large subunit biogenesis732.0×2e-07
ribosomal small subunit biogenesis1125.8×5e-11
rRNA processing1420.4×9e-13
translation1920.1×2e-17
RNA processing511.3×3e-03
nucleosome assembly710.1×3e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

55 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance41
Likely benign2
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

1174 predictions. Top by Δscore:

VariantEffectΔscore
22:37686473:GCG:Gdonor_gain1.0000
22:37686474:CGGTG:Cdonor_loss1.0000
22:37686476:G:Cdonor_loss1.0000
22:37686476:G:GGdonor_gain1.0000
22:37686476:GTGA:Gdonor_loss1.0000
22:37686477:T:Adonor_loss1.0000
22:37686477:T:Gdonor_loss1.0000
22:37687893:C:Aacceptor_gain1.0000
22:37687906:GTA:Gacceptor_loss1.0000
22:37687907:TAGGG:Tacceptor_gain1.0000
22:37687908:A:ACacceptor_loss1.0000
22:37687908:A:ATacceptor_loss1.0000
22:37687908:AG:Aacceptor_gain1.0000
22:37687908:AGGGA:Aacceptor_gain1.0000
22:37687909:G:GTacceptor_gain1.0000
22:37687909:G:Tacceptor_loss1.0000
22:37687909:GG:Gacceptor_gain1.0000
22:37687909:GGGA:Gacceptor_gain1.0000
22:37687909:GGGAG:Gacceptor_gain1.0000
22:37688000:G:GTdonor_gain1.0000
22:37688012:GGAG:Gdonor_gain1.0000
22:37688013:G:GTdonor_gain1.0000
22:37688013:GAG:Gdonor_gain1.0000
22:37688016:G:GAdonor_loss1.0000
22:37688016:G:GGdonor_gain1.0000
22:37688301:T:TAacceptor_gain1.0000
22:37688303:T:TAacceptor_gain1.0000
22:37688304:G:Aacceptor_gain1.0000
22:37688308:TCAGC:Tacceptor_loss1.0000
22:37688309:CAGC:Cacceptor_loss1.0000

AlphaMissense

1365 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
22:37687926:T:CF34L0.999
22:37687928:C:AF34L0.999
22:37687928:C:GF34L0.999
22:37688925:T:AV105D0.998
22:37686456:T:CF22L0.997
22:37686458:C:AF22L0.997
22:37686458:C:GF22L0.997
22:37687927:T:CF34S0.997
22:37687948:G:CR41P0.996
22:37687915:A:CY30S0.995
22:37687929:C:GH35D0.994
22:37686473:G:CR27S0.993
22:37686473:G:TR27S0.993
22:37687914:T:GY30D0.993
22:37687924:G:AG33D0.993
22:37687936:G:CR37P0.993
22:37688313:G:CR64P0.993
22:37686472:G:TR27M0.992
22:37687959:G:CA45P0.992
22:37686457:T:CF22S0.991
22:37687927:T:GF34C0.991
22:37688931:T:AV107E0.991
22:37687960:C:AA45D0.990
22:37686472:G:CR27T0.989
22:37687914:T:AY30N0.989
22:37687923:G:CG33R0.989
22:37687952:G:CK42N0.989
22:37687952:G:TK42N0.989
22:37687914:T:CY30H0.987
22:37687935:C:GR37G0.987

dbSNP variants (sampled 300 via entrez): RS1000819859 (22:37690157 G>A), RS1000875917 (22:37686765 C>G,T), RS1000890775 (22:37690451 T>C), RS1001241854 (22:37685460 A>C), RS1001640954 (22:37686268 G>A), RS1002007416 (22:37688250 C>A,G,T), RS1002205971 (22:37690892 C>A,G,T), RS1002627490 (22:37685852 T>C), RS1002674965 (22:37686215 G>C,T), RS1003570283 (22:37693020 G>A,C,T), RS1003629499 (22:37686997 G>A), RS1003682028 (22:37687161 G>A,T), RS1003701614 (22:37688146 G>A), RS1003925933 (22:37691758 C>T), RS1003980367 (22:37692500 T>C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST006629_43Pulse pressure5.000000e-11
GCST010703_11Brain morphology (MOSTest)9.000000e-10
GCST90002379_171Basophil count6.000000e-11

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0005763pulse pressure measurement
EFO:0004346neuroimaging measurement
EFO:0005090basophil count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

21 total (human), top 21 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Aciddecreases expression, increases expression2
FR900359affects phosphorylation1
triphenyl phosphateaffects expression1
bisphenol Adecreases expression1
trichostatin Aaffects expression1
sodium arsenitedecreases expression1
abrineincreases expression1
(+)-JQ1 compounddecreases expression1
Air Pollutantsaffects expression, increases abundance1
Atrazinedecreases expression1
Benzo(a)pyreneaffects methylation1
Caffeineaffects phosphorylation1
Carbamazepineaffects expression1
Copperaffects binding, decreases expression1
Disulfiramdecreases expression, affects binding1
Doxorubicinincreases expression1
Ozoneincreases abundance, affects expression1
Quercetindecreases phosphorylation1
Ribonucleotidesaffects binding1
Vincristinedecreases expression1
Cyclosporinedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.